Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-01

Clinical Trial Update: Neuromodulation of Inflammation and Vascular Function in Systolic Heart Failure [NA]

View source ↗

Summary

ClinicalTrials.gov update shows termination of a study investigating neuromodulation effects on inflammation and vascular function in heart failure with reduced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oklahoma | Conditions: Heart Failure With Reduced Ejection Fraction | NA | Status: TERMINATED